Pricing

ANTHERA PHARMACEUTICALS INC

0 followers ·
HAYWARD CA
Anthera Pharmaceuticals is based out of Hayward. Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on developing and commercializing therapeutics to treat diseases associated with inflammation, including cardiovascular and autoimmune diseases. Its primary product candidates include varespladib methyl (A-002), which has completed its Phase 2 clinical studies for the treatment of acute coronary syndrome; varespladib sodium (A-001) that is in a Phase 2 clinical study for the prevention of acute chest syndrome associated with sickle cell disease; and A-623, which has completed Phase 1 clinical studies for the treatment of B-cell mediated autoimmune diseases. The company has license agreements with Eli Lilly and Company, and Shionogi & Co., Ltd. to develop and commercialize secretory phospholipase A2 or sPLA2 inhibitors for the treatment of cardiovascular disease and other diseases; and Amgen Inc., to develop and commercialize A-623. Anthera Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Hayward, California.Whalewisdom has at least 2 13G filings, and 131 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2018-01-11. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security

Contact Info

Contact information is taken directly from publicly disclosed SEC filings.

ANTHERA PHARMACEUTICALS INC
25801 INDUSTRIAL BOULEVARD, SUITE B
HAYWARD CA    94545

Business Phone: (510) 856-5600
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Recent SEC Filings

Filing Date
3 2018-09-12
15-12B 2018-07-30
EFFECT 2018-07-26
EFFECT 2018-07-26
EFFECT 2018-07-26
EFFECT 2018-07-26
EFFECT 2018-07-26
EFFECT 2018-07-26
EFFECT 2018-07-26
S-8 POS 2018-07-20